| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.8 |